Evidence map›Paper›PMID 34699046›Full record

ArticleTherapeutic innovation & regulatory science2022

A Comprehensive Nomogram Combining CT Imaging with Clinical Features for Prediction of Lymph Node Metastasis in Stage I-IIIB Non-small Cell Lung Cancer.

Xingxing Zheng, Jingjing Shao, Linli Zhou, Li Wang, Yaqiong Ge, Gaoren Wang, Feng Feng

Abstract read
PubMed Publisher
In one paragraph

Article in Therapeutic innovation & regulatory science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Xingxing Zheng *Department of Radiology, Affiliated Tumor Hospital of Nantong University, No. 30 Tongyangbei Road, Tongzhou District, Nantong, 226361, China.
Jingjing Shao *Key Laboratory of Cancer Research Center Nantong, Affiliated Tumor Hospital of Nantong University, Nantong, 226361, China.
Linli ZhouDepartment of Radiology, Affiliated Tumor Hospital of Nantong University, No. 30 Tongyangbei Road, Tongzhou District, Nantong, 226361, China.
Li WangDepartment of Radiology, Baoji Central Hospital, Baoji, 721000, China.
Yaqiong GeGE Healthcare China, Shanghai, 210000, China.
Gaoren WangDepartment of Radiotherapy, Affiliated Tumor Hospital of Nantong University, Nantong, 226361, China. 995605535@qq.com.
Feng FengDepartment of Radiology, Affiliated Tumor Hospital of Nantong University, No. 30 Tongyangbei Road, Tongzhou District, Nantong, 226361, China. fengfeng1131@163.com.
Nantong University · CNBaoji City Central Hospital · CNUnited Imaging Healthcare (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe status of lymph node metastasis (LNM) is highly correlated with the recurrence and survival outcomes of patients with lung cancer. Thus, a tool that predicts LNM could benefit patient treatment and prognosis. The present study established a new radiomic model by combining computed tomography (CT) radiomic features and clinical parameters to predict the LNM status in patients with non-small cell lung cancer (NSCLC).

methodsDemographic parameters and clinical laboratory values were analyzed in 217 patients with stage I-IIIB NSCLC; 107 of the patients received CT scanning and radiomic characteristics were used for LNM assessment (76 in the training cohort and 31 in the validation cohort). The minimum redundancy maximum relevance (mRMR) and the least absolute shrinkage and selection operator (LASSO) regression model were used to select the most predictive features on the basis of the 76 patients in the training set. The value of the area under the receiver operator characteristic (ROC) curve (AUC) was adopted to determine the correlation between LN status and the radiomics signature in training cohorts and then validated in the 31 patients of validation set. The radiomics nomogram was analyzed using univariate and multivariate logistic regression. Decision curve analysis (DCA) was performed to evaluate the clinical utility of this model.

resultsThis was a retrospective study. Five radiomic characteristics were significantly correlated with LNM in the two cohorts (P < 0.05). The radiomic nomogram that incorporated the above radiomic characteristics, the RDW, and the CT-based LN status had satisfactory discrimination and calibration in the training (AUC, 0.79; 95% CI 0.69-0.89) and validation cohorts (AUC, 0.70; 95% CI 0.50-0.89).The DCA showed that the developed nomogram had promising clinical utility.

conclusionsThe developed nomogram, combined with preoperative radiomics evidence, the RDW, and the CT-based LN status, has the potential to preoperatively predict LNM with high accuracy and can facilitate the prediction of LN status for NSCLC patients.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsHumansLymphatic MetastasisLymph NodesNomogramsRetrospective StudiesTomography, X-Ray ComputedLymph node metastasis (LNM)NomogramNon-small cell lung cancer (NSCLC)RadiomicsRed blood cell distribution width (RDW)

Identifiers

PMID34699046
OpenAlexW3209277701

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.